(Baltimore, MD) — Emergent BioSolutions in Baltimore accidentally mixed ingredients from the Johnson & Johnson and AstraZeneca COVID vaccine, ruining 15-million doses of the J&J vaccine. In a statement, Johnson & Johnson says the issue was identified, addressed and shared with the Food & Drug Administration. The company is providing additional experts to be on-site at Emergent to supervise manufacturing of the J&J vaccine and will continue to work toward the Baltimore facility receiving Emergency Use Authorization. Current shipments of the J&J vaccine are not affected because they were made at a separate facility authorized by the FDA.
Johnson & Johnson Issues Statement On Vaccine Error
Current shipments of the J&J vaccine are not affected because they were made at a separate facility authorized by the FDA.